Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Discussion session - Sarcoma

4012 - Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.


22 Oct 2018


Poster Discussion session - Sarcoma



Tumour Site



Jean-Baptiste Delhorme


Annals of Oncology (2018) 29 (suppl_8): viii576-viii595. 10.1093/annonc/mdy299


J. Delhorme1, E. Nassif2, G. Ferron3, E. Bompas4, J. Adam5, O. Glehen6, A. Italiano7, F. Bertucci8, D. Orbach9, A. Le Cesne10, J.Y. Blay11, C.M. Chevreau12, O. Mir13, C. Honoré14

Author affiliations

  • 1 General And Digestive Surgery, Hautepierre University Hospital, 6700 - Strasbourg/FR
  • 2 Medical Oncology, Gustave Roussy Institut de Cancérologie, 94805 - Villejuif/FR
  • 3 Surgical Department, Centre Claudius-Regaud, 31052 - Toulouse/FR
  • 4 Medical Oncology, ICO Institut de Cancerologie de l'Ouest René Gauducheau, 44805 - Saint-Herblain/FR
  • 5 Pathology, Institut Gustave Roussy, 94800 - Villejuif/FR
  • 6 Surgical oncology, Centre Hospitalier Lyon Sud, 69495 - Pierre Bénite/FR
  • 7 Early Phase Trials Unit, Institute Bergonié, 33076 - Bordeaux/FR
  • 8 Medical Oncology, Institute Paoli Calmettes, 13274 - Marseille/FR
  • 9 Pediatric Oncology, Institut Curie, 75005 - Paris/FR
  • 10 Department Of Medicine, Gustave Roussy, University Paris-Saclay, 94800 - Villejuif/FR
  • 11 Medical Oncology, Centre Léon Bérard, 69008 - Lyon/FR
  • 12 31, Institut Universitaire du Cancer -Toulouse- Oncopole, 31059 - Toulouse/FR
  • 13 Cancer Medicine, Institut Gustave Roussy, 94800 - Villejuif/FR
  • 14 Surgery Department, Institut Gustave Roussy, 94800 - Villejuif/FR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 4012


Desmoplastic Small Round Cell Tumor (DSRCT) is a rare peritoneal disease affecting children and young adults. Despite a very poor prognosis, long-term survivors have been reported. the aim of the study is to identify in a nation-wide survey patients with a prolonged survival after DSRCT diagnosis and to identify factors associated with a cure.


All consecutive patients treated for DSRCT in 9 French expert centers between 1991 and 2018 were identified and retrospectively analyzed. Patients with a follow-up of less than 2 years were excluded from the analysis. Cure was defined as a disease-free survival of at least 5 years.


100 pts were identified (median age 25, 89% male). 27 had distant metastases at diagnosis. 80 pts underwent upfront chemotherapy and 51 pts were subsequently operated. 20 pts went directly to surgery. Surgery was macroscopically complete (CC0/1) in 50 pts. Intraperitoneal chemotherapy was associated to surgery in 17 pts. 54 pts had postoperative chemotherapy and 26 pts had postoperative whole abdomino-pelvic RT (WAP-RT). After a median follow-up of 124 months (range 23-311), the median overall survival (OS) was 25 months. 1- year, 3-year and 5-year OS rates were 90%, 35% and 4% respectively. 7 patients were considered cured after a median disease-free interval of 100 months (range 22-139). Predictive factor of cure were female sex (HR = 4.46, p = 0.005), median PCI<12 (HR = 4.53, p = 0.005), MD Anderson stage I (HR = 3.97, p = 0.003), CC0/1 (HR = 2.17, p = 0.05) and WAP-RT (HR = 3.41; p = 0.003). Neither Hyperthemic intraperitoneal chemotherapy (HIPEC) nor early postoperative intraperitoneal chemotherapy (EPIC) did increase the rate of cure.


Cure in DSRCT is possible in 7% of patients and is best achieved combining systemic chemotherapy, complete cytoreductive surgery and WAP-RT. Targeted treatments are urgently needed.

Clinical trial identification

Legal entity responsible for the study

Gustave Roussy.


Has not received any funding.

Editorial Acknowledgement


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.